Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies

Hematology/Oncology Clinics of North America 2026

View at publisher

Authors: Annie Xiao, Matthew Mei

DOI: 10.1016/j.hoc.2025.12.004

Cited by: 2

References: 70

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers CAR-T cell therapy research

References 70